Obalon Therapeutics News

Obalon Therapeutics | 424B3: Prospectus

Sep 21, 2021 16:10 ET

Obalon Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 21, 2021 09:00 ET

Obalon Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 18, 2021 16:05 ET

Obalon Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 18, 2021 09:28 ET

Obalon Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 13, 2021 16:01 ET

Obalon Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 4, 2021 16:07 ET

Obalon Therapeutics | EFFECT: Others

Apr 14, 2021 00:15 ET

Obalon Therapeutics | 424B3: Prospectus

Apr 13, 2021 16:22 ET

Obalon Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Apr 9, 2021 17:20 ET

Obalon Therapeutics | S-4: Registration of securities issued in business combination transactions

Mar 29, 2021 20:17 ET

Obalon Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 20, 2021 08:45 ET

Obalon Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 20, 2021 08:31 ET

Obalon Therapeutics | EFFECT: Others

Mar 2, 2020 00:15 ET

Obalon Therapeutics | 424B3: Prospectus

Feb 28, 2020 17:03 ET

Obalon Therapeutics | 424B4: Prospectus

Aug 2, 2019 17:40 ET

Obalon Therapeutics | EFFECT: Others

Aug 2, 2019 00:15 ET

Obalon Therapeutics | 424B5: Prospectus

Jun 7, 2019 17:01 ET

Obalon Therapeutics | 424B3: Prospectus

Feb 22, 2019 08:30 ET

Obalon Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Dec 27, 2018 17:12 ET

Obalon Therapeutics | 424B5: Prospectus

Dec 27, 2018 17:04 ET